Karla Montalbán-Hernández

5PUBLICATIONS
14CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2026
A Circulating Signature of Tumour Hybrid Cells and Immune Checkpoints Predicts Metastatic Progression in Lung Cancer.

Gonzalo Sáenz de Santa María-Diez, Sandra Liana Pardo-Prieto, Roberto Lozano-Rodríguez

|Feb 24, 2024
MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults.

Karla Montalbán-Hernández, Ana Cogollo-García, Patricia Girón de Velasco-Sada

|Sep 09, 2022
Fused Cells between Human-Adipose-Derived Mesenchymal Stem Cells and Monocytes Keep Stemness Properties and Acquire High Mobility.

Karla Montalbán-Hernández, Cesar Casado-Sánchez, José Avendaño-Ortiz

|Jul 27, 2022
Colorectal Cancer Stem Cells Fuse with Monocytes to Form Tumour Hybrid Cells with the Ability to Migrate and Evade the Immune System.

Karla Montalbán-Hernández, Ramón Cantero-Cid, José Carlos Casalvilla-Dueñas

|Jun 24, 2022
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment.

Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Raúl López

Pageof 1